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ABSTRACT
Objectives: The prevalence of typhoid fever was reportedly high, especially in the Asian continent, as many as 80% of cases came from slums in 
Bangladesh, China, India, Indonesia, Laos, Nepal, Pakistan, and Vietnam. Due to many cases of antibiotic resistance in typhoid fever, various efforts 
have been made by combining antibiotic therapy or active compounds with adjuvants and herbs. Curcumin is an active compound found in many 
herbal plants, especially in the Asian Continent. Curcumin has an antimicrobial effect, presumably due to its ability to bind Vitamin D receptors (VDR) 
as a potential ligand. This condition increases the expression of cathelicidin antimicrobial peptides and eradicates bacteria. Vitamin D will definitely 
bind to VDR as well; on this basis, this study wants to prove the effect of the combination of curcumin and Vitamin D therapy in inhibiting the growth 
of Salmonella typhi.
Methods: This study is a true experimental pre- and post-test design using colony calculation method to investigate the effectiveness of curcumin and 
Vitamin D in suppressing the growth of S. typhi bacteria in peritoneal fluid male mice strain balb/c. Mice were divided into five groups randomly, namely, 
the negative control groups, Group I (curcumin 200 mg/BB/day), Group II (curcumin 400 mg/BB/day), and Group III (curcumin 200 mg/BB/day and 
Vitamin D 200 IU/day), and the positive control groups (antibiotic levofloxacin). The intervention was carried out for 5 days. After the 5th day, mice 
were then maintained for 3 weeks to determine the amount of colony growth in the post-intervention period.
Results: The comparison of the results between each group gave significance in the average number of bacterial colonies of intraperitoneal fluid. 
Each group gave a significant difference of <0.05. Curcumin has an activity as an antimicrobial, the higher the dose, the greater the number of bacteria 
inhibited growth. After curcumin therapy, 200 mg/kg and 400 mg/kg for 5 days, a decrease in the number of bacterial colonies in the intraperitoneal 
fluid was found. This study concluded that curcumin has an antimicrobial effect on S. typhi. The groups with combination therapy of Vitamin D and 
curcumin intervention also gave the same results.
Conclusion: Based on the results of this study, the combination of curcumin and Vitamin D is able to inhibit the growth of S. typhi bacteria, even up 
to 30 days after infection.
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INTRODUCTION
Typhoid fever is a systemic infection caused by S. typhi. In 2004, the 
S. typhi bacterium was estimated to infect 21.7 million people and 
cause 217,000 deaths worldwide. The high incidence of typhoid fever 
(>100 cases/100,000 populations/year) was found in the continents of 
South Asia, Southeast Asia, and South Africa, with as many as 80% of 
cases coming from slums in Bangladesh, China, India, Indonesia, Laos, 
Nepal, Pakistan, and Vietnam [1].
Salmonella typhi or S. typhi is a Gram-negative Bacillus that causes 
typhoid fever in humans. This bacterium is able to survive in the 
phagosome so that it can escape the body’s immune system. Several 
complications of typhoid fever such as are ileal perforation, bacteremia, 
and endovascular infections [2,3].
The first antibiotic to treat typhoid fever was chloramphenicol, used in 
1948 and subsequently became the preferred therapy for up to three 
decades in addition to ampicillin and trimetoprim sulfamethoxazole [4,5]. 
The first report on S. typhi resistance to chloramphenicol in 1974 [6], 
20 years later reported S. typhi resistance against chloramphenicol, 
ampicillin, and trimetoprim sulfamethoxazole, otherwise known as 
multiple drug resistance S. typhi [7]. At present, the increase in S. typhi 
resistance to second-line therapy, third generation cephalosporins and 
quinolone groups have also been widely reported [8-11]. The main 
mechanisms of bacteria show resistance to antimicrobial agents can 
be caused by many factors including drug inactivation, reduced drug 
accumulation, and changes in metabolic pathways and targets [12,13].
Curcumin is known to have anti-inflammatory, anticancer, and 
antimicrobial effects. The curcumin antimicrobial mechanism 
correlates with its ability to bind the Vitamin D receptor (VDR) as a 
potential ligand. This condition increases the expression of cathelicidin 
antimicrobial peptides (CAMP) and eradicates bacteria. In addition, 
curcumin can increase CAMP mRNA expression so that it can increase 
cathelicidin levels in tissues [14]. Cathelicidin is a small peptide 
that has a similar structure to other antimicrobial proteins, such as 
defensins. Cathelicidin has the ability to eradicate Gram-positive and 
Gram-negative bacteria and also some fungi and parasites. Cathelicidin 
infiltrates bacterial membranes to change membrane integrity, but 
some bacteria are known to have intrinsic resistance to cathelicidin. 
Bacteria such as Enterococcus faecalis, Streptococcus pyogenes, and 
Proteus mirabilis, can synthesize certain protease enzymes that can 
destroy cathelicidin [15].
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In this study, a combination of curcumin and Vitamin D was carried out 
on Salmonella-induced mice. This is based on research by Wang et al., 
which shows that 1,25-dihydroxyvitamin D (Vitamin D3) can induce 
gene expression of two antimicrobial peptides, namely, cathelicidin and 
beta-2-defensins [16].
Due to the high number of cases on antibiotic resistance in typhoid 
fever, various efforts have been made by combining antibiotic therapy 
or active compounds with adjuvants and herbs. However, the research 
is not able to prove that this combination is useful for treating typhoid 
fever. Further researches are still needed to investigate the possible 
effects of this combination. This research is an exploratory study to 
ascertain the effect of curcumin combined with Vitamin D on S. typhi as 
a modality in inhibiting the growth of S. typhi bacteria.
Curcumin compounds
Curcumin is the main pigment found in Curcuma longa turmeric plants. 
Curcumin is commonly used as colorant for food. Besides, curcumin 
is also widely used traditionally for the treatment of skin diseases, 
respiratory related diseases such as sinusitis, asthma, phlegm thinners, 
treatment related to the digestive tract, abdominal pain, urinary tract 
infections, rheumatism, and hepatitis and treatment of women after 
childbirth [17].
Curcumin is a curcuminoid compound which is a yellow pigment in 
ginger and turmeric rhizome. This compound belongs to the phenolic 
group. The isolated curcuminoid is yellow or orange-yellow, and 
tastes bitter. Curcuminoid has a distinctive smell and is not toxic. The 
solubility of curcumin is very low in water and ether, but soluble in 
organic solvents such as ethanol and glacial acetic acid. Curcumin is 
stable in acidic conditions, but unstable under alkaline conditions 
and light. In alkaline conditions with pH above 7.45, 90% of curcumin 
is degraded to form a by-product in the form of trans-6-(4ˈ-hydroxy-
3ˈ-methoxyphenyl)-2.4-diocso-5-hexenal (majority), vanillin, ferulic 
acid, and feruloyl methane. With the presence of light, curcumin is 
degraded to vanillin, vanillic acid, ferrate aldehyde, ferulic acid, and 
4-vinylguaiacol [18].
The chemical structure of curcumin consisting of curcumin, 
demethoxycurcumin, and bisdemethoxycurcumin is shown in Fig. 1.
Effect of antimicrobial curcumin
In a study conducted by Ramprasad and Sirsi, it was shown that curcumin 
has antibacterial properties, especially against Micrococcus pyogenes 
var. aureus. Phenols and their derivatives in turmeric have been shown 
to have bactericidal and bactericidal properties so they are often 
used as disinfectants. Phenol compounds in curcumin function as an 
antimicrobials by denaturing cell proteins and damaging cell membranes. 
This compounds act actively against vegetative bacterial cells, but not 
against bacterial spores [19]. Curcumin presumed to have a structure 
similar to nordihydroguaiaretic (NDGA) compounds which have strong 
antibacterial properties. Research by Shih and Harris reported that 
NDGA at a concentration of 1000 ppm had a strong effect of lethality on 
Escherichia coli [20]. According to Winarsih et al. (2015), turmeric inhibits 
Gram-positive rod-shaped bacteria because of its curcumin content [21].
Research by Fauzah and Zulfah used five groups of E. coli bacteria with 
concentrations of Curcuma domestica 50%, 25%, 12.5%, 6.25%, and 
3.12%, and one cup as a positive control and one cup as negative control 
carried out for 1 month. The test results showed significant differences 
occurred in all test groups. This means that the use of turmeric extract 
can inhibit the growth of E. coli bacteria. The concentration of turmeric 
extract, which affects the growth of E. coli bacteria is 12.5%, 25%, and 
50% due to the active content of curcumin and essential oils [22].
Another study was conducted by Cut, to determine the antibacterial 
effect (inhibitory concentration) of turmeric extract on the growth 
of Bacillus sp. and Shigella dysenteriae bacteria. The effectiveness of 
turmeric extract test at a concentration of 15%, 30%, 50%, 75%, and 
100% was found to get the concentration of turmeric extract to inhibit 
the growth of S. dysenteriae bacteria and Bacillus sp. in the category 
of the weak inhibitor [23]. The similar result obtained in research 
by Yuliati, it was found that turmeric extract had more effective 
antibacterial activity on Bacillus sp. bacteria than against S. dysenteriae 
germs, even though the difference was not significant [24].
A study conducted by Tyagi et al. which aimed to investigate the 
antibacterial activity of curcumin toward four groups of bacteria, 
namely, Gram-positive (Staphylococcus aureus and E. faecalis) and 
Gram-negative (E. coli and Pseudomonas aeruginosa). The results proved 
membrane leakage in Gram-negative and Gram-positive bacteria on the 
exposure of curcumin [25]. A study by Rai et al. showed that curcumin 
could inhibit bacterial cell proliferation by inhibiting the dynamics of 
the FtsZ assembly (bacterial protofilament), which polymerized to 
form Z rings (Z-ring) in the middle of the cell that triggers bacterial 
cell division/proliferation. The assembly and stability of the FtsZ 
protofilament have been shown to play an important role in bacterial 
cytokinesis. As a result, curcumin inhibits the formation of a cytokinetic 
Z-ring, which will inhibit bacterial proliferation [26].
In vivo studies show that administering curcumin doses of 100 mg/kg, 
protects mice from pneumonia caused by S. aureus, including methicillin-
resistant strains (methicillin-resistant S. aureus), with a target of the 
α-hemolysin S. aureus protein [27]. Another in vivo study of mice 
induced with S. typhi, after 3 days of administering curcumin at a dose 
of 200 mg/kg, there were many bacterial colonies which were distal to 
the ileum. However, the number of colonies was reduced after 5 days of 
curcumin administration [28].
S. typhi
Salmonella has a variation of lengths. Most isolates are motile with 
peritrix flagella. Salmonella can grow easily on a simple medium, 
but almost never ferments lactose and sucrose. This bacteria does 
not produce gas on sugar fermentation. They generally produce H2S. 
This organism is able to survive in frozen water for a long period. 
Salmonella is resistant to certain chemicals (e.g., brilliant green, sodium 
tetrathionate, and sodium deoxycholate) which inhibit other enteric 
bacteria; thus, the addition of the substance to the medium is useful for 
isolating salmonella from feces [29].
S. typhi is a Gram-negative bacterial stem, which does not form a spore, 
is motile, and has capsules, and is flagella (moves with hair shakes). 
These bacteria can live at pH 6–8 at a temperature of 15–41°C (optimal 
temperature 37°C). These bacteria cannot survive at a temperature 
of 54.4°C for 1 h and 60°C for 15–20 min. These bacteria also cannot 
survive pasteurization, boiling, and chlorination [30].
METHODS
This research is a true experimental pre- and post-test design using 
colony calculation method to investigate the effectiveness of curcumin 
Fig. 1: Chemical structure of curcumin, demethoxycurcumin, and 
bisdemetoksikurkumin
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and Vitamin D in suppressing the growth of S. typhi bacteria in 
peritoneal fluid male mice strain balb/c.
Procedure
Preparation and adaptation for animal experiment
This stage is for the preparation and adaptation of animals 
experiment. Mice are placed in cages made of wire with a floor size of 
30 cm×50 cm×15 cm. The density of each cage contains six tails. Mice 
are given 300 g/day/head of food (feed), enough drink, and the cage is 
cleaned every day. To maintain a stable environmental atmosphere, mice 
are placed in a room with sufficient air circulation according to room 
temperature at standard conditions (28±2°C) with 50±10% humidity. 
The room light is also maintained with a 12 h cycle the light is turned on 
and 12 h extinguished. This procedure is carried out for 1 week.
After that, the randomization is carried out. All mice were grouped 
into five groups randomly, namely, the negative control group, Group I 
(curcumin 200 mg/BB/day), Group II (curcumin 400 mg/BB/day), 
and Group III (curcumin 200 mg/BB/day and Vitamin D 200 IU/day), 
and positive control group (antibiotic levofloxacin). The intervention 
was conducted for 5 days. After the 5th day, mice were then kept for 
3 weeks to determine the number of colonies in the post-intervention 
period.
Induction of S. typhi
In this stage, all mice were induced with intraperitoneal S. typhi of 0.2 
ml×105 ml/CFU.
Addition of curcumin
Curcumin in this research was purchased from Merck curcumin 
for synthesis, with the chemical formula [4-(OH)-3-(CH₃O)
C₆H₃CH=CHCO]₂CH₂. This is also known as 1,7-Bis (4-hydroxy-
3-methoxyphenyl)-1,6-heptadiene-3,5-dione, turmeric yellow, 
diferuloylmethane. The curcumin dose per day given is 200 mg/kg BB 
mice, 400 mg/kg BB mice, and 400 mg/kg BB plus Vitamin D. Curcumin 
therapy is given 3 days after induction by Salmonella bacteria. Curcumin 
is dissolved in distilled water and given through the nasogastric sonde 
for 5 days.
Addition of Vitamin D
Vitamin D in this research was purchased from Merck (colecalciferol 
and cholecalciferol). The dose of Vitamin D used in this study is in 
accordance with the dose of Vitamin D recommended for adults aged 
19–50 years, which is 200 IU/day. Calculation of the dose given to mice 
is obtained by multiplying it by a conversion factor of 0.0026. Group III 
was given a dose of 0.52 IU of Vitamin D/day for 5 days. Vitamin D is 
dissolved in distilled water and given through the nasogastric sonde.
Addition of levofloxacin
Levofloxacin was obtained from Kimia Farma, Pharmaceutical, 
Indonesia. Dose 750 mg of levofloxacin given to mice was obtained 
from multiplication with a conversion factor of 0.0026. Based on the 
result, the positive control group was given a dose of levofloxacin 
1.95 mg/day. Antibiotics are dissolved in distilled water and given 
through the nasogastric sonde for 1 week.
Sampling of peritoneal liquid
Mice are fixed in the supine position; the abdomen is cleaned with 70% 
alcohol and injected with 0.8–1 mL NaCl into the peritoneal cavity. 
Then, keep it still for 1 min while being shaked slowly. Peritoneal fluid 
is removed from the peritoneal cavity with a supine position; then, the 
liquid is aspirated with spoilted as much as 0.5 mL. The sampling of 
peritoneal fluid was carried out 3 times; on the 3rd day, after the mice 
were induced by S. tyhpi, the last day of the intervention and 3 weeks 
after the intervention.
Culture and calculation of colonies number
The pour plate method is a technique for growing microorganisms in 
gelatin as media by mixing the gelatin liquid with a bacterial culture 
stock (gelatin) so that the cells are spread evenly and quietly on the 
surface or inside of gelatin [31].
This method was carried out by diluting peritoneal fluid samples of 
0.5 mL into 4.5 mL of physiological salt (0.9% NaCl). Dilution is done 
3 times so that the culture obtained is not too dense or overfill the cup 
(too dense culture will interfere with the observation). About 1 ml 
of the suspension was poured into sterile Petri dishes, followed by 
pouring warm sterile nutrient media (45°C) and then tightly closed and 
incubated for 1–2 days at 37°C.
Data analysis
The results of the study were carried out by the Shapiro–Wilk normality 
test, to determine the normality of data distribution. Then, the Levene 
test is performed to determine the data variance. The normally 
distributed and homogeneous data are carried out by parametric 
one-way ANOVA test. Meanwhile, the data that were not normally 
distributed carried out with Kruskal–Wallis non-parametric tests. 
The test results showed significant data (p<0.05) followed by post hoc 
analysis to determine the differences between intervention groups.
RESULTS
The comparison of the results between each group gives a significance 
in the average number of bacterial colonies of intraperitoneal fluid. 
These results are shown in Table 1. Each group gives significance 
results <0.05. Curcumin has an activity as an antimicrobial, the higher 
the dose, the greater the number of bacteria inhibited growth. Fig. 2 
shows the average results of calculation of the Salmonella bacterial 
colonies before therapy intervention, after intervention for 5 days and 
3 weeks after therapy administrated.
DISCUSSION
After the Salmonella bacteria inside the body, it will go to the digestive 
tract, especially the ileum, and penetrate the blood vessels to spread 
systemically through circulation [32,33]. Most bacteria will be killed by 
stomach acid so that bacteria with such large amounts are needed to 
reach the intestine and can provide clinical manifestations [33].
Curcumin is an active compound that is widely known as an anti-
inflammatory, anticancer, and recently, antimicrobial agent. The results 
of the study Guo et al. showed that the antimicrobial mechanism of 
curcumin through its ability to bind to the VDR as a potential ligand. 
Table 1: Characteristics of data on the number of bacterial colonies in each group
Group n Pre‑test Post‑test Day 30 p*
Median SD Median SD Median SD
Curcumin 200 mg/kg 5 26.80 3.7 3.20 3.1 0.20 0.4 0.000
Curcumin 400 mg/kg 5 17.20 2.3 0 0 0.80 1.3 0.002
Curcumin 200 mg/kg and 0.52 IU Vitamin D 5 30.40 7.4 0.20 0.4 0.40 0.5 0.009
Levofloxacin 5 22.00 6.1 1.20 1.8 0 0 0.010
Aquades 5 21.80 6.4 6.00 2.8 1.20 1.3 0.003
*The mean difference is significant at the 0.05 level (ANOVA repeated test). SD: Standard deviation
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The bonds of curcumin and VDR will trigger the formation of CAMP 
to eliminate bacteria. In addition, curcumin can increase mRNA 
expression from CAMP so that it can increase the level of cathelicidin 
in the tissue [14]. Cathelicidin is a small peptide with some structural 
similarities with other antimicrobial proteins, such as defensins. 
Cathelicidin has a broad antibacterial spectrum toward Gram-positive, 
Gram-negative bacteria, fungi, and parasites. Cathelicidin damages 
bacterial membranes by changing membrane integrity, although 
some bacteria are known to have resistance to cathelicidin. The types 
of bacteria such as E. faecalis, S. pyogenes, Salmonella enterica, and 
P. mirabilis, can synthesize certain proteinases to reduce cathelicidin 
expansion [15]. Nevertheless, this study proved that curcumin still has 
an antimicrobial role against S. typhi.
After curcumin therapy, 200 mg/kg and 400 mg/kg for 5 days, a 
decrease in the number of bacterial colonies in the intraperitoneal fluid 
was found. This study concluded that curcumin has an antimicrobial 
effect on S. typhi. The group with combination therapy of Vitamin D 
and curcumin intervention also gave the same results. The number of 
bacterial colonies after 5 days of treatment showed a decrease in the 
number of bacterial colonies. Vitamin D can trigger the autophagy 
process toward Salmonella bacterial infection and modulate the 
inflammatory response that prevents the host from the detrimental 
effects of excessive inflammatory processes arising from infection [34]. 
Other studies proved the important role of Vitamin D in regulating 
innate immunity [35]. In response to pathogenic bacteria, the innate 
immune response triggers the production and release of antimicrobial 
peptides [16].
CONCLUSION
Based on the results of this study, a combination of curcumin and 
Vitamin D can inhibit the growth of S. typhi bacteria, even up to 30 days 
after infection.
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